Open App →
Back to News Feed
PR Newswire November 16, 2026 positive

Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology

<p>New three-year grant from the Gates Foundation extends a 2023 project to help global health researchers predict potential fetal development risks posed by novel drug candidates Evotec's human stem cell-based platform enables better-informed decisions regarding which drug candidates to...</p>
Read original article ↗